• SOHM, a generic drug manufacturing and distributing innovator, announced its development collaboration with the University of Arizona Center for Innovation (“UACI”) for the advancement of its ABBIE platform
• In the arrangement, SOHM will establish offices and a wet lab bench, taking advantage of UACI’s robust and specialized infrastructure
• SOHM’s management is optimistic about the collaboration and is confident that this is but the first step toward deepening new lab operations
• It also marks a significant milestone, as it anticipates monetizing ABBIE off-the-shelf, non-viral gene editing kits

SOHM (OTC: SHMN), a generic drug manufacturing and distributing innovator, just announced its development collaboration with the University of Arizona Center for Innovation (“UACI”) for the advancement of its revolutionary ABBIE platform. This marks a significant milestone for SOHM, notably as it anticipates monetizing ABBIE off-the-shelf, non-viral gene editing kits through licensing opportunities as early as 2024 (https://ibn.fm/ZM4JH).

UACI expressed optimism in the arrangement, citing their confidence in ABBIE thriving through the program.

“We are delighted to assist SOHM and the development of ABBIE technology. UACI offers comprehensive support, including SBIR grant assistance, access to core research facilities, award opportunities, and investor networking,” noted Eric Smith, UACI’s Executive Director.

“Our Good Laboratory Practice (‘GLP’) facilities provide an ideal environment for technology growth, from conceptualization to clinical application. We are confident that ABBIE will thrive through our program,” he added.

In the arrangement, SOHM will establish offices and a wet lab bench, taking advantage of UACI’s robust and specialized infrastructure and a best-practice environment with certified GLP. It is confident that going with UACI would help fast-track development, ultimately allowing it to achieve its 2024 goal of taking the technology to market.

ABBIE, SOHM’s flagship offering, is a platform for non-viral gene editing technology that enables the rapid introduction of genes of interest while offering same-day screening. Given its potential, SOHM looks to develop and deploy non-viral gene-editing kits that will be developed into cell-based therapies, biologics, and diagnostics, ultimately allowing it to tap into the global biotechnology kit market, which is estimated to post a 10.9% CAGR between 2023 and 2030.

Industry experts have lauded non-viral gene-editing platforms, noting that they are at the forefront of research and development in genetics. In addition, they have highlighted their potential to treat genetic diseases while advancing biological research. More importantly, they have noted that non-viral gene-editing methods have shown potential in eliminating concerns related to immune responses, insertional mutagenesis associated with viral vectors, safety, and efficiency, as associated with current alternatives in the market.

SOHM’s management is optimistic about the collaboration and is confident that this is the first step toward deepening new lab operations.

“Having experienced the university’s world-class research facilities firsthand, I am confident in the success of ABBIE under this collaboration,” noted Dr. David Aguilar, SOHM’s COO.

“UACI has supported the company’s development. We recognize that this relationship will only deepen with the new lab operations,” he added.

For more information, visit the company’s website at www.SOHM.com.

NOTE TO INVESTORS: The latest news and updates relating to SHMN are available in the company’s newsroom at https://ibn.fm/SHMN

• As a European innovator with a worldwide outlook, Turbo Energy designs devices that showcase how AI can be applied to enhance everyday living with advanced software systems that monitor the generation, use, and management of photovoltaic energy
• Turbo Energy’s SunBox, or what the company calls one of the most advanced systems on the market, does not just aim to save power; it seeks to empower users with smart tools that help them make energy choices that suit their lifestyle
• Expanding beyond residential applications, Turbo Energy introduced commercial and industrial-scale solutions in 2023 and aims for a global footprint in fourteen countries

A decade ago, Turbo Energy (NASDAQ: TURB) surfaced as a company focused on disruptive photovoltaic energy technology. Its ambitious goal was to transform storage technology for off-grid residences. Now, integrated into a group boasting more than 20 years of industry experience, the company is unwaveringly committed to developing innovative photovoltaic management solutions tailored for residential, commercial, and industrial markets.

A device capable of connecting to everything—a lofty statement that, upon closer inspection of Turbo Energy’s SunBox Home technical details, appears to hold up. Marketed by the company as the most complete all-in-one device on the market, SunBox packs in inverters, batteries, and protective features, all rolled into one piece (https://ibn.fm/SbkM1).

While artificial intelligence (“AI”) applications continue to capture widespread attention across various facets of modern life and business, the application of AI in SunBox merits a closer examination. As users consume and generate photovoltaic (“PV”) power, the integrated AI system collects and analyzes this data along with weather information and energy prices. The goal is simple: manage household energy consumption efficiently and cost-effectively.

AI-powered SunBox Home seeks to put the power in users’ hands, offering a personalized experience with choices ranging from maximizing self-consumption to optimizing savings on electricity bills. In a climate where the financial strain on homeowners is palpable, AI-driven SunBox’s customizable modes aim to be more than a mere nod to energy efficiency; they seek to become a smart ally for homeowners navigating the challenges of rising living costs.

The flexibility extends to designating specific battery segments for blackout protection, with the AI seamlessly managing the intricate details. Users can also exercise control over energy delivery by selecting which storage section handles excess consumption.

In the face of increasingly unpredictable weather, SunBox Home steps up again to provide reassurance for homeowners. Its Activate smart storm protection system monitors the weather forecast, ensuring batteries are fully charged when storms are on the horizon.

After a decade dedicated to perfecting this innovative product tailored for the residential market, Turbo Energy appears to show no signs of slowing down. Building on its existing technical expertise, the company expanded into the EV segment in 2022, launching Sunbox with an integrated charger for electric vehicles. What seems to set Sunbox apart is its claim to fame as the only EV charger offering three charging modes along with its sophisticated AI algorithm, empowering homeowners to charge their vehicles directly with renewable energy at the lowest costs and highest speed.

But Turbo Energy’s growth trajectory appears to extend beyond product diversification; it also aims to encompass a strategic foray into new markets. Having solidified its position in Spain, the company embarked on a European expansion journey two years ago. Building on the success of its European growth, Turbo Energy now eyes expansion, with imminent operations launching in South America from its Chilean office (https://ibn.fm/VPOHP). The North American market is next on the agenda, with initial steps anticipated in 2024 (https://ibn.fm/eD2PB). According to its current expansion plans, Turbo Energy aims to extend its international footprint from nine to 14 countries, with the United States, Canada, Mexico, Chile, Peru, and Colombia featured as new spots on its international roadmap.

For more information, visit the company’s website at www.Turbo-e.com.

NOTE TO INVESTORS: The latest news and updates relating to TURB are available in the company’s newsroom at https://ibn.fm/TURB

• Security tokens and tokenized securities are gaining attention as the drivers of evolution in companies’ investment platforms, but the two digital offerings have distinct qualities that explain their differing trajectories
• Tokenized securities’ links to specific off-chain assets and mimicry of established asset groups have thus far given them the advantage over the broader base of investment in security tokens that has attracted the attention of SEC regulation enforcers
• Utah-based Diamond Lake Minerals is building a portfolio of vertically integrated, industry-agnostic subsidiaries dedicated to regulatory compliance while opening doors to digital assets for traditional investors wary of digital assets
• DLMI’s strategy has led its market cap to grow exponentially from around $1 million to more than $100 million in about three months’ time, following years of relatively stagnant performance

The advent of tokenized assets and their upward spring in the marketplace is reflected in the rapid growth multi-strategy operating company Diamond Lake Minerals (OTC: DLMI) is experiencing in the wake of its reinvention from mining holding enterprise to the digital asset and security token space.

Tokenized securities have enjoyed a much less bumpy adoption trajectory than the somewhat analogous (but not entirely homologous) digital tokens that have been enjoying media attention because of U.S. Securities and Exchange Commission (“SEC”) enforcement actions against companies using tokens to fund their operations.

Security tokens are “blockchain-based representations of certain privileges such as revenue sharing, access, governance rights or a combination of these and others,” while tokenized securities are “tokens that represent either specific off-chain assets, or that mimic established asset groups such as bonds, shares or funds,” a CoinDesk article noted earlier this year (https://ibn.fm/gWWX4). “All tokenized securities could be classified as security tokens, but not all security tokens are tokenized securities. … The two concepts on the surface may appear similar but lift the lid and you can see that the difference is stark: It’s about clarity and establishment support versus the lack thereof.”

Diamond Lake Minerals is developing its operation by building a vertically integrated ecosystem of numerous industry-agnostic holdings and imbuing each with an SEC-registered security token offering (“STO”). The result is a portfolio of widely varied subsidiaries that will share resources and support one another while they’re growing and developing self-sufficiency, using STOs dedicated to each subsidiary as a means to attract traditional investors otherwise unfamiliar with digital assets but dependent on regulatory compliance.

Diamond Lake works with regulated SEC security token exchange partner INX to provide access to its companies before public trading commences. The INX Token was the first SEC-registered security token to IPO on the blockchain, and it relies on the checks and balances developed in traditional economic environs to provide a secure trading experience for all traders.

Diamond Lake’s market capitalization had held relatively steady at around $1 million for years, but following the introduction of experienced new management team members and advisers, as well as the rebrand to focus on digital assets during the past three months, DLMI’s cap has grown to over $100 million.

“I believe DLMI is the hybrid missing piece to get generational wealth, or the wealth on the sidelines,” CEO Brian J. Esposito said during a November Bell2Bell podcast interview (https://ibn.fm/0dej9).

“We’ll have media, we’ll have healthcare, … we’ll have music and IP, we’ll have the entertainment industry, we’ll have real estate opportunities,” Esposito said. “And (we’ll be) doing that in the correct fashion.”

For more information, visit the company’s website at www.DiamondLakeMinerals.com or LinkedIn page at www.LinkedIn.com/company/Diamond-Lake-Minerals/.

In addition, for information on the company’s security token SEC regulated exchange partner INX, and the development of the INX Way, visit https://www.inx.co/inx-ebook/. This free security token bible, written with the SEC on the rollout of security tokens and the future of digital assets, will greatly deepen your understanding of security tokens.

NOTE TO INVESTORS: The latest news and updates relating to DLMI are available in the company’s newsroom at https://ibn.fm/DLMI

• In November 2023, the company announced a purchase order from a Romanian company for seven TRACER 1000 ETDs to be deployed in a European airport
• Astrotech announced in June 2023 that its board unanimously rejected an unsolicited acquisition proposal from BML Investment Partners
• In May 2023, the company announced a purchase order from a Romanian company for 17 TRACER 1000 ETDs, to be delivered during calendar 2023
• Astrotech confirmed test results from field trials of the AgLAB 1000-D2 mass spectrometer for hemp and cannabis producers, improving yields by an average of 24%
• In December 2022, the company effected a 1-for-30 reverse stock split, reducing the number of outstanding common shares

Astrotech (NASDAQ: ASTC) is an instrumentation company that designs, manufactures and commercializes solutions. Its solutions include mass spectrometry, process controls, chemical detectors and medical disease detection.

The company was established in 1984 and, prior to 2009, was known as SPACEHAB Inc., a NASA contractor offering technology originally developed for NASA to monitor air quality on the International Space Station. When the Space Shuttle program ended, the company focused on its satellite processing and mass spectrometer instrumentation units and adopted the Astrotech name.

In 2014, Astrotech sold its satellite subsidiary to focus on its Astrotech Technology Inc. (“ATi”) mass spectrometry solutions, which offer a number of advantages over competing platforms. Notably, Astrotech’s ATi technology is ruggedized, rapid, simple to use and customizable, with hands-free calibration and tuning.

Between 2016 and 2019, the company secured U.S. patents for its technology and achieved European Union (“ECAC”) certification for the TRACER 1000(TM), the world’s first mass-spec Explosives Trace Detector (“ETD”) used in airports worldwide. Astrotech continues to innovate and add to its suite of products, including AgLAB-1000, a process control system, and the BreathTest 1000, a disease detection solution.

Astrotech is headquartered in Austin, Texas.

Subsidiaries

Astrotech Technologies Inc.

Astrotech Technologies Inc. (“ATi”) owns and licenses the platform mass spectrometry technology originally developed by 1st Detect. This technology is designed to be less expensive, smaller and easier to use than traditional mass spectrometers.

Unlike other technologies, ATi works under high vacuum, which eliminates competing molecules, yielding higher resolution and fewer false alarms. The company’s intellectual property includes 18 granted patents, along with extensive trade secrets.

ATi exclusively licenses the Astrotech Mass Spectrometer Technology to the three wholly owned subsidiaries of Astrotech.

1st Detect Corp.

1st Detect Corp. developed the TRACER 1000, the world’s first mass spectrometry-based explosives and narcotics trace detector. 1st Detect ETDs were developed for use at airports, cargo facilities and other secured locations and borders worldwide.

1st Detect’s commercial sales of the TRACER 1000 ETD, consumables and recurring maintenance services brought in $750,000 in total revenue during the fiscal year ended June 30, 2023. The Astrotech subsidiary recently secured two orders for a total of 24 Tracer 1000 units from two Romanian security and telecommunications companies, to be delivered during calendar 2023.

AgLAB Inc.

AgLAB Inc. is developing a series of mass spectrometers for use in the hemp and cannabis market, with an initial focus on optimizing yields in the distillation processes.

AgLAB, which uses the company’s proprietary AgLAB 1000-D2(TM) mass spectrometer, has been proven to improve distillation oil yields and bottom-line profits for hemp and cannabis producers. During field trials, AgLAB was able to improve ending-weight yields by an average of 24%.

BreathTech Corp.

BreathTech is developing the BreathTest-1000(TM), a breath analysis tool to screen for volatile organic compound (“VOC”) metabolites found in a person’s breath that could indicate they may have a compromised condition including but not limited to a bacterial or viral infection. The company believes that new tools to aid in the battle against COVID-19 and other diseases remain of the utmost importance to help more quickly identify that an infection may be present.

Market Opportunity

A report by Mordor Intelligence, a research and advisory firm, put the global mass spectrometry market at $6.37 billion in 2023. The market is forecast to grow to $8.63 billion by 2028, achieving a CAGR of 6.25% during the forecast period.

One of the major driving factors for the growth of the mass spectrometry market is technological advancements in mass spectrometer devices, the report states. Key market players are continuously working toward advancing their existing products and launching innovative and advanced mass spectrometer devices.

Another major factor that is expected to boost market growth is increasing research and development expenditure by both government and private entities, according to the report. Mass spectrometry devices are also being used in the detection and analysis of COVID-19 and other disease samples, which may have a positive impact on the market.

Management Team

The Astrotech leadership team includes management executives, as well as industry and technology experts. The company continues to actively expand its talent pool to meet evolving demands.

Thomas B. Pickens III is Chairman, CEO and Chief Technology Officer of Astrotech Corp. He also serves as CEO of Astrotech subsidiaries ATi, 1st Detect, AgLAB Inc. and BreathTech Corp. Previously, he was the founder and president of Beta Computer Systems Inc. and T.B. Pickens & Co. He was founder and general partner of Grace Pickens Acquisition Partners L.P and managing partner of Sumpter Partners. He also served as CEO of Catalyst Energy Corporation and United Thermal Corporation and as president of Golden Bear Corp., United Hydro Inc. and Slate Creek Corp. He received a B.A. in Economics, Computer Science and Engineering from Southern Methodist University.

Jaime Hinojosa, CPA, is CFO at Astrotech Corp. He joined the company in 2015 and has served as its Corporate Controller since 2019. His previous roles with the company include Director of Finance, from 2017 to 2019, and Assistant Controller, from 2015 to 2017. Prior to joining Astrotech, Mr. Hinojosa worked as an Accounting Manager for O’Reilly Auto Parts and gained public accounting experience as an Audit Manager at Burton McCumber & Cortez LLP.

For more information, visit the company’s website at www.AstrotechCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to ASTC are available in the company’s newsroom at https://ibn.fm/ASTC

• Astiva Health currently offers Medicare Advantage health plans in two heavily populated southern California counties; the company is planning to expand its operation in northern California and other states
• The company serves and supports an underserved Vietnamese-American population
• The company plans to expand its successful culturally responsive strategies to serve other ethnic populations
• Astiva Health has strategically positioned itself in a region with a dynamic and diverse population
• Astiva’s forward-thinking investment in sustainable growth aligns with evolving healthcare dynamics, ensuring the company remains resilient and transformative in meeting the diverse needs of communities

Astiva Health is a dynamic and innovative Medicare Advantage Prescription Drug (“MAPD”) healthplan committed to reshaping the landscape of personalized and comprehensive healthcare. The company offers full medical, drugs and supplemental benefits for Medicare enrollees currently located in Orange and San Diego County of California.

Astiva Health primarily serves a heretofore underserved Asian American and Pacific Islander population, which positions it in a critical and expanding market segment and offers substantial growth potential. The company recognizes the diverse needs within its served communities and strives to bridge healthcare gaps through proactive and culturally responsive solutions.

Astiva Health cares about its members and works to establish lifelong relationships with them by providing a tailored approach to healthcare, offering multilingual solutions for customer service, marketing materials and educational resources. Health is an essential key to living a good life, and Astiva Health makes it a priority to help members love the life they live.

The company’s mission is to deliver an unparalleled level of quality care to its members. Astiva Health’s Medicare Advantage plans provide lower costs and additional benefits beyond original Medicare coverage.

Founded in southern California, Astiva Health has strategically positioned itself in a region with a dynamic and diverse population. The organization’s extensive network and culturally responsive approach to healthcare make it well-suited to cater to the needs of the local community, creating a competitive advantage in the market.

The company is based in Orange, California.

Healthcare Model

Astiva Health is not just another healthplan. The company considers the uniqueness of its members and, therefore, the means for delivering quality care to each one. To best serve its members, Astiva Health has developed one of the most diverse networks in southern California, offering a selection of medical, drugs, and supplemental benefits including dental, acupuncture, vision and hearing plans tailored to the specialized needs of individual members.

The company’s health plans provide increasing levels of benefits to members in the counties it serves. Astiva Health’s Customer Care Support and representatives are available to assist members with any issues.

The organization’s proactive approach to overcoming language barriers for the Vietnamese communities demonstrates a commitment to inclusivity and enhances accessibility – a key factor for future growth. The successful implementation of strategies for the Vietnamese community sets a precedent for Astiva Health’s ability to adapt and apply similar approaches to serve other ethnic groups in future expansions, broadening the potential impact of its services.

The company provides members access to experienced and dedicated providers and local pharmacies that work together with each member to pave a pathway toward better health. The company’s online directory provides members with a comprehensive list of providers to fit their specialized needs.

Astiva Health collaborates with a variety of partners who offer supplemental benefits to members beyond Medicare. Those benefits include transportation, vision, dental, hearing, fitness, tele-health, acupuncture and chiropractic. Astiva’s forward-thinking strategy not only fulfills a critical societal need but also ensures sustainable growth and transformative impact across diverse communities.

Market Opportunity

Medicare Advantage plans, since their establishment in 2008 as a lower-cost alternative for Medicare enrollees looking to save on monthly premiums, have been one of the fastest growing segments of the health insurance market.

According to a report by healthcare consultant Chartis, nearly 31 million beneficiaries are enrolled in a Medicare Advantage plan in 2023, accounting for more than 48% of the total Medicare market. That represents 9.6% enrollment growth over 2022 totals, and the pace of growth is likely to continue, according to the Chartis report.

Startup Medicare Advantage plans, a sector that includes Astiva Health, grew even faster for 2023, at a rate of 22% over 2022 totals.

Management Team

Dr. Tri T. Nguyen is co-founder and CEO of Astiva Health. He is a graduate of Stanford Medical School and is a board-certified expert in internal medicine, cardiovascular disease and interventional cardiology. As founder, CEO and owner/operator of Avanta IPA, he is a committed leader in healthcare. His visionary leadership, hands-on experience and deep industry knowledge uniquely position him to guide Astiva to success.

Chi Luong is CFO at Astiva Health. She founded and operates HADD Group LLC, a company managing medical clinic services, including business contracting, finance, staffing and ancillary support for several medical clinics in San Diego. She is responsible for the expansion and daily operation of the business functions of the medical clinics managed by HADD Group, and she has extensive knowledge and experience in healthcare business development.

Viet Tran has over 30 years of experience in engineering research, development and management. He has made numerous contributions to national network security and technology. He led the initial Naval Interoperability Profiles that set a solid foundation for future naval airborne network development. He also led a team of 50 engineers, doctorates and scientists delivering an airborne network system for the Navy’s first carrier-based unmanned aircraft. As Astiva Health’s Chief Operating and Technology Officer, member satisfaction has been his top priority. He is committed to protecting valuable data for Astiva members and providers. He constantly strives for leaner and more effective operations.

Tyler Diep is Vice President, Sales, Marketing and Provider Relations at Astiva Health. His responsibilities include handling special projects for the board of directors, as well as overseeing the sales, marketing and provider relations department. During his tenure, he tripled the membership of Astiva Health. He previously served as councilman and vice mayor of the City of Westminster, California. He immigrated to the U.S. with his parents and graduated from San Diego State with a bachelor’s degree in public administration.

For more information, visit the company’s website at www.AstivaHealth.com. 

NOTE TO INVESTORS: The latest news and updates relating to Astiva Health are available in the company’s newsroom at https://ibn.fm/Astiva

• Israel passed the Electronic Monitoring Bracelet Law in June 2023, allowing courts to monitor abusers through electronic monitoring (EM), a practice already employed in a growing number of other countries
• SuperCom’s PureSecurity Electronic Monitoring Suite has been used in other countries to monitor domestic violence offenders, including use as part of Romania’s first electronic monitoring program
• The company is seen at the forefront when it comes to advances in EM technology for domestic violence applications

In late June 2023, the Israeli government passed the Electronic Monitoring Bracelet Law, which National Security Minister Itamar Ben-Gvir proposed. The purpose of the law is to allow the court to impose monitoring of abusers through an electronic monitoring solution, which keeps the person under surveillance and monitored in real time. Israel is not the first country to use electronic monitoring devices for domestic violence offenders. Countries including Romania, Sweden, and the United States, have all used this technology to help prevent additional domestic violence cases.

SuperCom (NASDAQ: SPCB), a leading global provider of traditional and digital identity solutions, providing advanced safety, identification, and security products and solutions to governments and private and public organizations, is at the forefront of domestic violence electronic monitoring technology advances. Located in Tel Aviv, Israel, SuperCom is positioned to provide the proposed monitoring solutions to the local government in Israel, as it has to other governments worldwide.

Other countries have deployed SuperCom’s PureSecurity Electronic Monitoring Suite for domestic violence monitoring. The PureSecurity Suite is an electronic monitoring and tracking platform that features a comprehensive set of innovative features, including:

• Advanced anti-tampering mechanisms
• Multi-factor biometrics
• Newest location technology and sensors
• Practically limitless historic data
• Seamless 3rd party API integration
• Ultra-lightweight ankle bracelet with proprietary energy efficiency algorithms

SuperCom’s PureSecurity Suite has been deployed in several countries – including use as the first electronic monitoring project in Romania, announced in August 2022. “We are excited with the execution of this contract; it further validates our strategy to scale up operations to accelerate growth and improve public safety in more nations worldwide,” said SuperCom’s President and CEO, Ordan Trabelsi, during the project’s first phase (https://ibn.fm/Qd9nw). “We look forward to supporting Romania’s public safety efforts and bringing them the many benefits of SuperCom’s proprietary EM technology. It is an honor to take part in this national initiative by building the necessary infrastructure and deploying Romania’s first EM program.”

Since the successful implementation of the first phase, the Romanian government has issued a second order for SuperCom’s services, valued at approximately $7.1 million. Trabelsi said that with this additional order, SuperCom continues to solidify its position as a leader in the electronic monitoring market and as a trusted partner to governments worldwide (https://ibn.fm/5AGwx). “With a pipeline of over $200 million of potential projects, a strong base of recurring revenues, and high win rates in competitive tenders, we continue to execute our global growth strategy.”

Since 1988, SuperCom has been a global provider of traditional and digital identity solutions. The company’s proprietary PureSecurity Suite of hardware, connectivity, and software components is the foundation for its criminal justice services, including domestic violence monitoring. Each of SuperCom’s electronic monitoring services is custom-tailored to meet the needs of the client requesting them – ensuring that individual needs are addressed by the unit commissioned.

With the passing of Israel’s new electronic monitoring law, defendants in domestic violence cases are subject to electronic monitoring if the court finds them dangerous or if they have been convicted of domestic violence in the past. SuperCom offers proprietary EM solutions that support a wide array of programs such as GPS Monitoring, house arrest, domestic violence, and more. SuperCom’s offering includes a diverse portfolio of monitoring solutions, including the PureOne, PureTrack, PureProtect, PureCom, Purebeacon, and PureTag products.

For more information, visit the company’s website at www.SuperCom.com.

NOTE TO INVESTORS: The latest news and updates relating to SPCB are available in the company’s newsroom at http://ibn.fm/SPCB

• The 2023 Nobel Prize in Chemistry, awarded to Moungi G. Bawendi, Louis E. Brus, and Aleksey Yekimov for their efforts in discovering and synthesizing quantum dots, recognizes the power of nanotechnology
• Nanoscience is the study of structures and molecules whose sizes range between 1 and 100 nm, while nanotechnology is the technology that utilizes nanoscience in practical applications
• The applications of nanotechnology are wide-ranging, from industrial-scale catalysis and modern electronics to precision medicine and quantum technology
• Clene Inc., a late clinical-stage biopharmaceutical company, has applied nanotechnology alongside other science concepts in the development of catalytically active nanocrystals
• The catalytic activities of the nanocrystals drive, support, and maintain beneficial metabolic and energetic cellular reactions within diseased, stressed, and damaged cells

The Royal Swedish Academy of Sciences (“the Academy”), which is responsible for awarding Nobel Prizes in Chemistry and Physics, decided to award this year’s Nobel Prize in Chemistry to Moungi G. Bawendi, Louis E. Brus, and Aleksey Yekimov for their efforts in discovering and synthesizing quantum dots, nanometer-sized semiconductor crystals that bring colored light to TV screens with Q-LED technology (https://ibn.fm/shWLi). The 2023 Nobel Prize in Chemistry recognizes the power of nanotechnology and the importance of quantum dots in nanotechnology.

Although the origins of nanotechnology predate the trio of laureates, their work was “part of the earliest wave of modern nanotechnology where researchers began putting breakthroughs in material science to practical use,” according to Andrew Maynard, Professor of Advanced Technology Transitions at the Arizona State University (https://ibn.fm/oiB0C). The Academy agrees, noting in a document that gives the scientific background of the 2023 Nobel Prize in Chemistry that “The discovery of quantum dots, and the ability to synthesize such materials with high accuracy but relatively simple chemical methods, was an important step in the development of nanoscience and nanotechnology…  it inspired many chemists to engage in [nanoscience]” (https://ibn.fm/ldISn).

Nanoscience is the study of structures and molecules whose sizes range between 1 and 100 nm, while nanotechnology is the technology that utilizes nanoscience in practical applications (https://ibn.fm/q1DzU). Nanotechnology is about harnessing properties that scientists in the field of nanoscience discover to improve the performance of materials or enable entirely new applications. Presently, the applications of nanotechnology range from industrial-scale catalysis and modern electronics to precision medicine and quantum technology. And with research ongoing, new applications and discoveries are a feasible possibility, as Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company, has demonstrated.

Clene and its wholly owned subsidiary, Clene Nanomedicine Inc., united concepts from electrochemistry, material science, plasma and quantum physics, biochemistry, and, most importantly, nanotechnology to create and refine a proprietary electro-crystallization method that results in clean-surfaced, highly faceted, and biologically catalytically active nanocrystals. The catalytic activities drive, support, and maintain beneficial metabolic and energetic cellular reactions within diseased, stressed, and damaged cells.

Based on these beneficial capabilities, Clene is developing a broad and deep pipeline of novel clean-surfaced nanotechnology (“CSN(R)”) therapeutics aimed at addressing a range of diseases, including amyotrophic lateral sclerosis (“ALS”), multiple sclerosis (“MS”), and Parkinson’s disease.

As the 2023 Nobel Prize in Chemistry continues to spotlight nanotechnology and particularly quantum dots, one thing stands out that perhaps also shines this light on Clene’s nanoparticles. Though markedly different, quantum dots and Clene’s catalytically active nanocrystals share one fundamental trait: some of their individual properties can be tuned using the same single parameter – the particle’s size. Just as the different sizes of quantum dots cause them to emit various colors, the sizes of the nanocrystals impact their catalytic activities, according to Clene. (In addition to the size factor, the catalytic activities of the nanocrystals are also determined by their shape, faceting, and chemical composition.)

“Our CSN platform has demonstrated flexibility in its ability to make, for instance, both pure gold and gold-platinum nanocrystals of consistent and reproducible shapes and sizes, in addition to making solutions of ionic zinc and silver. Because of the ease with which new single elemental and composite nanocrystals can be made of varying shapes and sizes using our proprietary techniques, we plan to continue developing a wide range of CSN therapeutics to generate a deep pipeline of drug candidates to treat a host of different diseases,” the company explained in its 2022 annual report (https://ibn.fm/JWVYB).

So far, Clene has developed CNM-Au8, its lead drug candidate, which is an oral suspension of clean-surfaced, catalytically active gold nanocrystals. The company is investigating CNM-Au8 as a disease-modifying treatment for ALS, MS, and Parkinson’s disease. Other products include CNM-ZnAg, a proprietary zinc-silver ionic solution; CNM-AgZn17, a topical gel polymer suspension of silver and zinc ions; and CNM-PtAu7, a gold-platinum nanotherapeutic (https://ibn.fm/JNFh3).

For more information, visit the company’s website at www.Clene.com.

NOTE TO INVESTORS: The latest news and updates relating to CLNN are available in the company’s newsroom at https://ibn.fm/CLNN

• GEMXX reported significant growth in its Q2 2023 revenue and net income, with the company anticipating additional growth and increased production of its gold assets in 2024
• GEMXX, in partnership with Crazy Horse Mining Inc., proved the commercial viability of the Snow Creek gold mine and is looking to similarly prove the viability of the Rosella Creek gold asset in 2024
• For the balance of 2023 and into 2024, the company is targeting additional acquisitions, more mine production, and more revenues, and plans to expand gemstone and jewelry production by 300% in 2024

GEMXX (OTC: GEMZ), a company specializing in gold mining and production and distribution of jewelry and gemstones on a global scale, supplying its own mined resources, shared positive financial results for the second quarter of fiscal 2023, ended September 20, 2023, and provided business and mining updates. Key highlights included a near-60% year-over-year increase in its net income to $212,526 from $132,842 in the same period last year and revenue growth YTD to $418,115 in the just-ended quarter up from $388,717 in Q2 2022 and $183,673 in Q1 2023. The company reported that its total assets had increased to $20,116,566, up from $18,400,825 in Q2 2022, and that its long-term debt remains at $0.00 (https://ibn.fm/RVX6m).

“We are pleased with the performance of the company, and we are excited for the anticipated growth in shopping television sales and 2024 production of our gold assets. We look forward to updating shareholders as each new project comes online. Everything the company has planned is focused on driving shareholder value,” conveyed Jay Maull, GEMXX CEO.

GEMXX’s focus on driving shareholder value saw the company complete the acquisition of 50% of Crazy Horse Mining Inc. (“CHMI”), a Canadian company with significant gold assets, including its mineral assets located in British Columbia, Canada, according to a May 23 news release (https://ibn.fm/iqrJ7). CHMI’s principal gold exploration assets include the Snow Creek and Rosella Creek projects, as well as additional options on mining claims located in British Columbia. The Snow Creek project covers 498 acres, of which about 80% is mineable, while the Rosella Creek project occupies an area of 240 acres, with approximately 90% being mineable.

“The acquisition of the Snow Creek and Rosella Creek gold asset portfolio enhances the company’s long-term asset expansion plan and helps to de-risk revenues, but most importantly, it complements our Ammolite production with the world’s most sought-after commodity, GOLD” said Maull of the acquisition.

Since May, GEMXX has made several strides and achieved significant milestones, which the company documented in a November 7 mining update (https://ibn.fm/5qx03). The update emphasized the company’s continued commitment to maintaining control over every stage of its production and operation, from gold mining and gemstone production to jewelry manufacturing and worldwide distribution, stressing that the company has been able to continue its expansion efforts while avoiding long-term debt.

According to the update, GEMXX, in partnership with CHMI, proved the commercial viability of the Snow Creek gold mine, having successfully completed gold production at the test site for the 2023 mining season. As part of the test and mining exercise, a total of 31,200 cubic yards of gold-bearing ore was processed, yielding 0.929 ounces per 100 cubic yards. These commercial production results met all expectations, according to the company, proving that the project is worth scaling up in 2024 (https://ibn.fm/8oVqF).

Accordingly, GEMXX has included in its 2024 objectives plans to upscale the gold mine operation with the aim of tripling production at the Snow Creek Mine site. In the meantime, however, GEMXX is compiling all test and mining results from the 2023 mining season in order to use them as part of the information required to complete an S-K 1300-compliant resource report.

The November 7 update also highlighted that GEMXX and CHMI are working closely to maximize resources and equipment to operate both the Snow Creek and the Rosella Creek gold mines in 2024. In 2024, the test plant used at the Snow Creek site will be transferred to Rosella Creek to prove the commercial viability of the project.

In addition, through the update, GEMXX notified investors of ongoing preparations to open an Ammolite mine on the company’s south block, possibly in early 2024, and plans to expand gemstone and jewelry production by 300% in the coming year. Moreover, the company is working to complete due diligence and the 50% acquisition of the historic Yukon Gold Property by the end of the 2023 calendar year. The NI 43-101 Resource Report, akin to the S-K 1300 report, completed by parties unaffiliated with GEMXX, confirms that the property holds 2,210,660 ounces of proven gold resources (https://ibn.fm/lI8A5).

For the remainder of 2023 and into 2024, the company is focused on expansion and adding shareholder value, which means additional acquisitions, more mine production, and more revenues.

Those interested in becoming a GEMXX investor are encouraged to visit the company’s investor page (https://ibn.fm/XKt4s) or contact company officials for more information (ir@gemxx.com – 702-930-1815).

For more information, visit the company’s website at www.GEMXX.com/investors.

NOTE TO INVESTORS: The latest news and updates relating to GEMZ are available in the company’s newsroom at https://ibn.fm/GEMZ

• SenesTech, experts in animal fertility control, posted a 44% YOY revenue growth for Q3 2023
• Gross profit also saw 49% growth from $122,000 in 2022 to $175,000 in 2023
• The growth was attributed to the company’s primary initiatives to drive sales, improve product quality, and expand product options
• The company looks to greatly accelerate growth with the launch of its Evolve Soft Bait, key to opening the huge professional rodent control market, and the first and only soft bait developed to control pest populations through technology that targets the population where it starts, without poisons

SenesTech (NASDAQ: SNES), an animal fertility control innovator and the inventor of the only EPA-registered contraceptive for male and female rats, announced its financial results for the third quarter of the 2023 financial year (“Q3, 2023”) on November 9, 2023. Of note was the 44% year-over-year (“YOY”) growth in revenue, primarily attributed to the company’s initiatives to drive sales, improve product quality, and expand product options.

“We accelerated our growth trajectory during the third quarter with strong 44% year-over-year growth in revenues driven by the initiatives we have undertaken to drive sales, improve our product quality, and expand our product options,” noted Joel Fruendt, SenesTech’s President and CEO (https://ibn.fm/e4qRg).

Revenue for Q3 2023 stood at $360,000, up from $250,000 in Q3 2022. Gross profit also saw a 49% growth, from $122,000 in 2022 to $175,000 in 2023. Sales growth was driven by the increases in every key market segment, including but not limited to commercial, agribusiness, zoos, and sanctuaries. SenesTech’s e-commerce platform also saw a decent return on marketing investment, a positive uptick following the successful reconfiguration of operations earlier in the year.

SenesTech plans to capitalize on this growth and accelerate it in the coming months and years to create value for its shareholders and stamp its position as an industry leader. The company is currently launching its Evolve Soft Bait, the first and only soft bait developed to control pest populations. It is a healthy addition to its growing product line, which currently comprises Ultimate, Isolate, and Elevate, pest bait systems delivered in liquid form. This foray into non-liquid baits, represented by Evolve, is key to tapping the vast professional market by offering a non-liquid bait form that fits the preferences of rodent control specialists.

With each product offering or iteration, SenesTech has pushed the envelope, providing more value to consumers and differentiating itself from its industry peers with unique technology. For instance, when it introduced Elevate in 2022, it offered a targeted approach to above ground rat infestations with easier deployment in rafters of barns, storage and manufacturing facilities, attics, and granaries.

The company looks to initially focus on commercial markets and key distributors. In addition, the company looks to explore e-commerce providers like Amazon and big box retailers, bringing the product closer to its target consumers. SenesTech is optimistic that this offering will yield significant additional growth.

“We expect this growth to further accelerate as we launch our Evolve Soft Bait, the first and only soft bait developed to control pest populations using a breakthrough technology that targets the rat population where it starts, by restricting fertility through nonlethal methods,” noted Mr. Fruendt.

Their most recent addition, Evolve, is specifically designed to be highly palatable to rats and easy to deploy. It also offers diverse placement in different environments, allowing for its application in parks, sports venues, food processing facilities, subways, agribusiness, residential locations, and recreational facilities. With SenesTech’s distribution, paired with the product’s competitive pricing compared to rodenticide alternatives, the company looks to carve out a significant market share and grow its revenues even further as time progresses.

For more information, visit the company’s website at www.SenesTech.com.

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

• This week’s New to the Street episode revolves around a recent cyberattack targeting ICBC (Industrial and Commercial Bank of China Limited), the world’s largest bank
• ICBC and its subsidiary, ICBC Financial Services, fell victim to a crippling ransomware attack, resulting in a system shutdown
• Sekur’s secure email solution operates exclusively on the company’s wholly-owned servers, safeguarding both senders and recipients, even if the latter is not a Sekur subscriber

New to the Street TV, a leading financial and business news show, recently sat down with Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FRA: GTD0) CEO Alain Ghiai to discuss the recent cyberattack on one of China’s largest financial institutions. The Weekly Hack segment brings Mr. Ghiai, TV co-host, and multimedia journalist Ana Berry to discuss security and privacy issues sweeping the nation.

The focal point of this episode revolves around a recent cyberattack targeting ICBC (Industrial and Commercial Bank of China Limited), the world’s largest bank (https://ibn.fm/hY95q). ICBC and its subsidiary, ICBC Financial Services (“FS”), fell victim to a crippling ransomware attack, resulting in a system shutdown. The consequences were dire, with approximately $9 billion worth of US Government Bond trades and other financial transactions unable to settle, causing significant turbulence in the financial markets.

Mr. Ghiai, drawing on his extensive expertise, speculates that the cyberattack compromised the bank’s corporate email system, paving the way for the ransomware intrusion. What struck him as unusual was the shift of executives to using Gmail accounts for communication when the corporate system was offline, underscoring the inherent cybersecurity risks associated with open-platform, free Big Tech email services.

Mr. Ghiai takes the opportunity to share the origins of Sekur, a company he founded a decade ago in response to the Sony Pictures Entertainment hack. Since its inception, Sekur has rolled out an array of subscription-based products tailored for individuals and businesses. Notably, SekurMail, featuring the innovative SekurSend/SekurReply feature, significantly reduces the likelihood of a cyber breach.

This secure email solution operates exclusively on Sekur’s wholly-owned servers, safeguarding both senders and recipients, even if the latter is not a Sekur subscriber. Importantly, Sekur refrains from third-party platforms or software, ensuring all offerings are encrypted and closed-looped.

Another vital component of Sekur’s comprehensive privacy solutions is SekurVPN, which offers users a Swiss VPN IP address, effectively concealing their online presence in Switzerland. This strategic approach virtually eradicates the tracking of users’ web traffic. All electronic communications by Sekur subscribers are routed through the company’s proprietary data servers in Switzerland, a nation known for having the strictest privacy laws globally.

Sekur is offering viewers an exclusive opportunity to subscribe using the PROMO CODE: PRIVACY, which grants a 15% discount on all products and bundled services for the next five years to demonstrate its commitment to privacy. It is essential to emphasize that Sekur never engages in data selling, never requests phone numbers, abstains from utilizing third-party cloud applications, and refrains from tracking web traffic.

For more information, visit the company’s website at www.SekurPrivateData.com or the company’s product site at www.Sekur.com.

NOTE TO INVESTORS: The latest news and updates relating to SWISF are available in the company’s newsroom at https://ibn.fm/SWISF